EU begins real-time review of Sanofi-GSK Covid-19 vaccine

EU begins real-time review of Sanofi-GSK Covid-19 vaccine The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early-stage clinical trials in adults, the European Medicines Agency (EMA). https://ift.tt/eA8V8J